<DOC>
	<DOCNO>NCT02235155</DOCNO>
	<brief_summary>The primary goal examine efficacy feasibility mifepristone-misoprostol medical abortion regimen terminate pregnancy 13-22 week Uzbekistan .</brief_summary>
	<brief_title>Mifepristone Misoprostol Midtrimester Termination Pregnancy Uzbekistan</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Meet legal criterion obtain abortion Have ongoing pregnancy 1322 week gestation Be willing undergo surgical completion necessary Have contraindication study procedure , accord provider Be willing able consent procedure , either read consent document consent document read Be willing follow study procedure Known previous transmural uterine incision Known allergy mifepristone misoprostol/prostaglandin contraindication use mifepristone misoprostol Any contraindication vaginal delivery , include placenta previa</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>